Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Virtu Financial
VIRT
$5.3B
| $2.64M | ﹤0.01% |
144,405
-10,521
| -7% | -$171K |
|
3102
ProShares Ultra Russell2000
UWM
$251M
| $2.64M | ﹤0.01% |
74,806
+52,406
| +234% | +$1.79M |
|
|
JKS
3103
PUT
JinkoSolar
JKS
$877M
| $2.64M | ﹤0.01% |
109,800
-106,600
| -49% | -$2.68M |
|
3104
CALL
Franco-Nevada
FNV
$45.2B
| $2.64M | ﹤0.01% |
33,000
-19,000
| -37% | -$1.53M |
|
|
TDAY
3105
USA Today Co
TDAY
$1.03B
| $2.64M | ﹤0.01% |
157,160
-144,567
| -48% | -$2.35M |
|
3106
PUT
Willis Towers Watson
WTW
$30.8B
| $2.64M | ﹤0.01% |
17,500
+11,400
| +187% | +$1.8M |
|
|
FRGI
3107
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $2.64M | ﹤0.01% |
138,764
-27,824
| -17% | -$501K |
|
3108
Hershey
HSY
$37B
| $2.63M | ﹤0.01% |
23,213
-229,572
| -91% | -$25.3M |
|
3109
Iron Mountain
IRM
$38.5B
| $2.63M | ﹤0.01% |
+69,817
| New | +$2.77M |
|
|
ITCI
3110
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.63M | ﹤0.01% |
181,938
+114,606
| +170% | +$1.77M |
|
|
ACET
3111
DELISTED
Aceto Corp
ACET
| $2.63M | ﹤0.01% |
255,056
-60,522
| -19% | -$636K |
|
|
PR
3112
Permian Resources
PR
$18B
| $2.63M | ﹤0.01% |
132,992
+112,319
| +543% | +$2.18M |
|
|
INST
3113
DELISTED
Instructure, Inc.
INST
| $2.63M | ﹤0.01% |
79,482
+56,023
| +239% | +$1.91M |
|
|
HA
3114
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.63M | ﹤0.01% |
66,000
-2,600
| -4% | -$100K |
|
|
FOLD
3115
PUT
DELISTED
Amicus Therapeutics
FOLD
| $2.63M | ﹤0.01% |
182,700
+21,400
| +13% | +$294K |
|
3116
Five Point Holdings
FPH
$371M
| $2.63M | ﹤0.01% |
186,461
-425,692
| -70% | -$5.8M |
|
3117
CALL
Royal Bank of Canada
RY
$301B
| $2.63M | ﹤0.01% |
32,200
-2,000
| -6% | -$159K |
|
|
ESV
3118
CALL
DELISTED
Ensco Rowan plc
ESV
| $2.63M | ﹤0.01% |
111,125
+30,025
| +37% | +$665K |
|
3119
DTE Energy
DTE
$29.3B
| $2.62M | ﹤0.01% |
28,124
+13,679
| +95% | +$1.3M |
|
3120
The Ensign Group
ENSG
$10.6B
| $2.62M | ﹤0.01% |
126,179
+43,452
| +53% | +$933K |
|
3121
PUT
Owens Corning
OC
$12.2B
| $2.62M | ﹤0.01% |
28,500
-2,100
| -7% | -$177K |
|
3122
CALL
Melco Resorts & Entertainment
MLCO
$2.17B
| $2.62M | ﹤0.01% |
90,100
-68,300
| -43% | -$1.74M |
|
3123
PUT
Celanese
CE
$5.01B
| $2.61M | ﹤0.01% |
24,400
-3,500
| -13% | -$372K |
|
3124
Carriage Services
CSV
$579M
| $2.61M | ﹤0.01% |
101,654
-3,132
| -3% | -$79.9K |
|
|
CLGX
3125
DELISTED
Corelogic, Inc.
CLGX
| $2.61M | ﹤0.01% |
56,476
-251,061
| -82% | -$11.6M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.